Search
for
Sort by
Research 211–240 of 1000+
- Cutaneous Sequelae After Burn Injury: Pruritus, Dyspigmentation and Malignancy—Mechanisms and Management
- Development of PEGylated Liposomes
- Anthracycline analogs The past, present, and future
- Polietilen glikol kaplı manyetik nanoparçaıkların sentezi ve karakterizasyonu ve anti-kanser ilaç taşınmasında kullanımı.
- Exploring the therapeutic potential of Selaginella doederleinii extract for cervical cancer treatment through network pharmacology and in vitro studies
- B/N-doped carbon nano-onions as nanocarriers for targeted breast cancer therapy
- Glibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231
- Clinical risk factors associated with intraoperative floppy iris syndrome: a prospective study
- Septin4 promotes cell death in human colon cancer cells by interacting with BAX
- A Case Report: Treatment of Anaplasmosis and Ectoparasitic Infestation in Mixed-Breed Golden Retriever Dog
- Hair loss and bronze discoloration of the skin in lupus erythematosus
- Cytotoxic Potential of Mangifera indica L var Arumanis Rind Extract and Fraction Against T47D Cells with Microtetrazolium (MTT) Method
- Effect of thalidomide combined with CHOP on patients with peripheral T-cell lymphoma
- Faculty Opinions recommendation of Targeted skin overexpression of the mineralocorticoid receptor in mice causes epidermal atrophy, premature skin barrier formation, eye abnormalities, and alopecia.
- Role of liposomal anthracyclines in the treatment of multiple myeloma
- Medikamentöse Therapie des benignen Prostatasyndroms mit α1-Rezeptorblockern Grundlagen und klinische Ergebnisse
- Liposomes in cancer therapy
- Clinical Development of Topoisomerase-Interactive Drugs
- Clomipramine suppresses ACE2-mediated SARS-CoV-2 entry
- Prevention of chemotherapy drug-mediated human hair follicle damage: combined use of cooling with antioxidant suppresses oxidative stress and prevents matrix keratinocyte cytotoxicity
- Key Clinical Trials in BPH
- Where it all went right
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Dermatologic therapy: December 1987 to December 1988
- MP24-09 MEN WITH AN IMPROVEMENT IN URINARY SYMPTOMS HAVE A LOWER RISK OF MORTALITY
- Recent studies on the delivery of hydrophilic drugs in nanoparticulate systems
- Updates in therapeutics for folliculitis decalvans: A systematic review with evidence-based analysis
- Direct Vasodilators and Sympatholytic Agents
- Hydrogel-Forming Microneedles for Transdermal Drug Delivery